ReviewACS omega2026
The Role of Membranes in Tissue Regeneration Therapy: State of the Art and Future Perspectives.
Review in ACS omega, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Membranes for tissue regeneration are an indispensable class of biomaterials in regenerative medicine, serving as selective barriers and matrices for the reconstruction of various tissues. Essential characteristics for the clinical success of a biomaterial include its biocompatibility, degradation kinetics, mechanical properties, and bioactivity, which are the focus of this review, with an emphasis on the importance of immunomodulation and the host response. The main clinical applications of this class of biomaterials are directed towards bone, cartilage, skin, and neural regeneration. In addition to evaluating the essential characteristics of these membranes, innovations such as smart, stimuli-responsive, and bioelectric membranes, as well as advances in 4D bioprinting, were also addressed. It is concluded that, despite established clinical success, the main challenges lie in overcoming material variability, vascularizing large-volume defects, and translating advanced technologies into clinical practice. Future perspectives point towards the development of personalized, smart, and bio-instructive membranes capable of actively orchestrating the regeneration process.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.